Natural Killer Group 2D (NKG2D) ligand, expressed on about 80% of MM cells, can bind to NKG2D on natural killer cells, leading to immune escape and tumor growth [112,113]. The gene discussed is KLRK1; the disease is Miyoshi myopathy.